Related Experiment Video
Updated: Apr 3, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
Participant Satisfaction With a Preference-Setting Tool for the Return of Individual Research Results in Pediatric
Ingrid A Holm1, Brittany R Iles2, Sonja I Ziniel3
1Boston Children's Hospital, MA, USA Harvard Medical School, Boston, MA, USA ingrid.holm@childrens.harvard.edu.
Insights
Allowing participants to choose which individual research results (IRRs) they receive from genomic biobanks increases satisfaction. This preference-based approach may also boost participation in vital biobank research.
Area of Science:
- Genomic research
- Biobanking ethics
- Participant engagement
Background:
- The value of returning individual research results (IRRs) to participants in genomic biobank research, based on their preferences, remains uncertain.
- Genomic biobanks collect vast amounts of data, raising ethical considerations regarding data sharing and result disclosure.
Purpose of the Study:
- To assess participant satisfaction with different policies for returning individual research results (IRRs) from genomic biobanks.
- To evaluate the impact of a preference-setting tool on participant experience and perceptions of biobank benefit.
Main Methods:
- Development of an online tool allowing participants to set preferences for receiving IRRs based on condition preventability and severity.
- Randomized hypothetical scenarios assigning parents of pediatric patients to four biobank policies: None, All, Binary (all or none), or Granular (using the preference tool).
- Survey distributed to 11,391 parents, with 2,718 completing the study assessing satisfaction with the biobank and IRRs.
Main Results:
- The 'Granular' group, utilizing the preference-setting tool, reported the highest satisfaction with the process, biobank, and received IRRs.
- The 'None' group exhibited the lowest satisfaction and were least likely to perceive the biobank as beneficial (p < .001).
- No significant difference in perceived harm of the biobank was observed across the groups.
Conclusions:
- Enabling participants to customize their preferences for receiving individual research results enhances satisfaction with genomic biobanks.
- The ability to designate preferences for IRRs may be a key factor in increasing participation and engagement in biobank research.
- Preference-based return of results aligns participant expectations with biobank operations, fostering trust and perceived value.
Abstract:
The perceived benefit of return of individual research results (IRRs) in accordance to participants' preferences in genomic biobank research is unclear. We developed an online preference-setting tool for return of IRRs based on the preventability and severity of a condition, which included an opt-out option for IRRs for mental illness, developmental disorders, childhood-onset degenerative conditions, and adult-onset conditions. Parents of patients <18 years of age at Boston Children's Hospital were randomized to the hypothetical scenario that their child was enrolled in one of four biobanks with different policies for IRRs to receive (a) "None," (b) "All," (c) "Binary"--choice to receive all or none, and (d) "Granular"--use the preference-setting tool to choose categories of IRRs. Parents were given a hypothetical IRRs report for their child. The survey was sent to 11,391 parents and completed by 2,718. The Granular group was the most satisfied with the process, biobank, and hypothetical IRRs received. The None group was least satisfied and least likely to agree that the biobank was beneficial (p < .001). The response to the statement that the biobank was harmful was not different between groups. Our data suggest that the ability to designate preferences leads to greater satisfaction and may increase biobank participation.
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Genomics

